Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
4.
Saudi Med J ; 26(6): 1033, 2005 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15983708
6.
Arch Pathol Lab Med ; 128(9): 1023-7, 2004 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-15335253

RESUMO

OBJECTIVE: To review and update the literature on current trends with regard to Pneumocystis carinii (jiroveci ) diagnosis, treatment modalities, and its role in human disease processes. DATA SOURCES: Bibliographic databases (PubMed and Ovid) were searched for material and data between 1980 and September 2003 relevant to the review. Indexing terms used were "Pneumocystis carinii pneumonia," and "Pneumocystis jiroveci," with the English language as a constraint. Other sources were the PhD thesis of one of the authors (J.F.W., London University, 1993) and the library at the Arabian Gulf University in the Kingdom of Bahrain. STUDY SELECTION: Acquired immunodeficiency syndrome and organ transplant cases with Pneumocystis carinii pneumonia. DATA EXTRACTION: Independent extraction by 2 observers. DATA SYNTHESIS: We reviewed the major characteristics of P carinii (jiroveci ) with special emphasis on the more recently acquired data including the presence of a round pore in the cyst wall, which appears to be used for the release of sporozoites, supporting the hypothesis of sexual reproduction in P carinii (jiroveci ). CONCLUSIONS: Opportunistic infection with P carinii (jiroveci ) remains a significant cause of morbidity and mortality in human immunodeficiency virus and non-human immunodeficiency virus-associated immunosuppressed patients. Diagnosis may be achieved in the majority of cases by routine cytochemical stains and specialized techniques such as immunocytochemistry and polymerase chain reaction. The incidence of P carinii pneumonia can significantly be reduced with effective use of prophylaxis and early detection of cases at high risk. Immunization for P carinii pneumonia is in the early stages and presents a challenging area for research.


Assuntos
Pneumocystis carinii , Pneumonia por Pneumocystis , Animais , Humanos , Pneumocystis carinii/classificação , Pneumonia por Pneumocystis/diagnóstico , Pneumonia por Pneumocystis/prevenção & controle , Pneumonia por Pneumocystis/terapia
8.
Pediatr Infect Dis J ; 22(1): 43-7, 2003 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-12544408

RESUMO

BACKGROUND: Little is known about causes of death among children seriously affected by the AIDS epidemic in southern African countries. METHODS: Autopsies were performed on 47 children 1 month to 13 years of age in Francistown, Botswana, between July 1997 and July 1998. RESULTS: Median age was 10 months; 68% were HIV-positive. The leading cause of death was respiratory infection, accounting for 29 of 35 (83%) deaths among HIV-positive and 8 of 12 (67%) deaths among HIV-negative children. Among HIV-positive children, Pneumocystis carinii pneumonia (PCP) was responsible for 31% of all deaths and for 48% of deaths in infants < or =1 year. Among children < or =2 years with cough and dyspnea, age < or =1 year, interstitial infiltrate and HIV positivity were highly predictive of PCP (sensitivity, 100%; specificity, 63%). CONCLUSION: Respiratory disease accounted for most deaths in HIV-positive children. Children < or =1 year who are known or suspected to be HIV-positive and who have cough, dyspnea and pulmonary infiltrates should be treated presumptively for PCP.


Assuntos
Infecções Oportunistas Relacionadas com a AIDS/mortalidade , Infecções Oportunistas Relacionadas com a AIDS/patologia , Infecções por HIV/complicações , Infecções Respiratórias/mortalidade , Infecções Respiratórias/patologia , Infecções Oportunistas Relacionadas com a AIDS/complicações , Adolescente , Botsuana/epidemiologia , Causas de Morte , Feminino , Infecções por HIV/epidemiologia , Soronegatividade para HIV , Soropositividade para HIV/complicações , Hospitais Pediátricos , Humanos , Lactente , Masculino , Admissão do Paciente , Valor Preditivo dos Testes , Infecções Respiratórias/complicações , Sensibilidade e Especificidade , Tuberculose Pulmonar/complicações , Tuberculose Pulmonar/mortalidade , Tuberculose Pulmonar/patologia
9.
Saudi Med J ; 24(12): 1296-9, 2003 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-14710272

RESUMO

Histiocytic proliferations may be reactive or neoplastic. The neoplastic proliferations (histiocytoses) are subdivided into a few categories. One of these categories is the non-Langerhan's cell histiocytoses (NLCH). Cutaneous NLCH is a heterogeneous collection of conditions which can be sub grouped on the basis of the morphological appearance of the lesional histiocyte into xanthomatized, oncocytic, vacuolated, spindle-cell and polymorphous subtypes. The clinical characteristics and histological appearances of a variety of conditions within each subtype are discussed.


Assuntos
Histiócitos/classificação , Histiocitose/patologia , Neoplasias Cutâneas/patologia , Biópsia por Agulha , Diagnóstico Diferencial , Feminino , Histiocitose/diagnóstico , Humanos , Imuno-Histoquímica , Masculino , Prognóstico , Medição de Risco , Dermatopatias/diagnóstico , Dermatopatias/patologia , Neoplasias Cutâneas/diagnóstico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA